ONCOPATHOLOGY AND CANCER IMMUNOTHERAPY

Immunotherapy emerged as a promising strategy cancer treatment, revolutionizing the field by harnessing the body's own immune system to target and destroy cancer cells. Unlike traditional treatments like chemotherapy and radiation therapy, which directly target cancer cells, immunotherapy works by enhancing the immune response to recognize and eliminating cancer cells more effectively! Several types of immunotherapies have been developed, including immune checkpoint inhibitors, CAR-T cell therapy, tumor-infiltrating lymphocytes (TILs), cytokine therapy, TCR-T, ICIs. These therapies have demonstrated remarkable success in some types of cancer, leading to durable responses and improved survival rates for patients! However, challenges remain, including understanding why some patients respond better than others, managing immune-related adverse events, and overcoming resistance to immunotherapy. Ongoing research efforts aim to address these challenges and further optimizing immunotherapy approaches. In conclusion, immunotherapy represents a paradigm shift in cancer treatment offering new hope to patients, paving the way for continued advancements in the field! With further research and development, immunotherapy holds the potential to transform cancer care and improve outcomes for patients worldwide.